Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

RPR describes novel farnesyltransferase inhibitors

April 28, 1997

Matrix initiates phase II trial of IntraDose in liver cancer

April 28, 1997

Schering-Plough and Myriad Genetics enter into strategic collaboration

April 28, 1997

Demeter reports results with Peptidyl MIM in animal model of prostate cancer

April 25, 1997

Titan issued U.S. patent for cancer vaccine

April 25, 1997

Antitumor agents described by Sagami

April 25, 1997

Genzyme Transgenics and NCI collaborate to expand cancer vaccine trials

April 24, 1997

Xytronyx's immunotherapy shows positive preclinical results

April 24, 1997

Triptorelin + melatonin for prostate cancer

April 23, 1997

Antiangiogenic effects of flavopiridol

April 23, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...